Expression of OAS2 has been suggested as a biomarker for disease and it has been reportedly upregulated in psoriasis and squamous cell carcinoma patients (54) and in mice in response to cigarette smoke and influenza virus (55). This evidence concerns the gene OAS2 and psoriasis.